Accessibility Menu
WuXi AppTec logo

WuXi AppTec(OTC) WUXIF

Current Price$22.70
Market Cap$66.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)+97%
5 Year-1%
1 Year+214%
1 Month+45%
WuXi AppTec last closing stock price
MetricPriceDate
Last closeUSD 22.702026-07-24
WuXi AppTec stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+8.39%USD 20.942026-07-17
1 month+45.23%USD 15.632026-06-24
3 month+65.69%USD 13.702026-03-25
Year to date+69.1%USD 13.422025-12-05
1 year+214.24%USD 7.222025-07-22
3 year+182.71%USD 8.032023-07-24
5 year-1.11%USD 22.952021-07-19
Since inception+96.91%USD 11.532020-03-17

WuXi AppTec Financials at a Glance

Market Cap

$66.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥48.22B

Net Income (TTM)

CN¥20.13B

EPS (TTM)

$0.96

P/E Ratio

22.99

Dividend

$0.23

Beta (Volatility)

0.15 (Low)

Price

$22.70

Volume

106

Open

$22.70

Previous Close

$22.70

Daily Range

$22.70 - $22.70

52-Week Range

$7.32 - $22.70

Estimated Earnings Date

Aug 3, 2026

WUXIF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About WuXi AppTec

WuXi AppTec Co., Ltd. is a leading global provider of research, development, and manufacturing services for the pharmaceutical and biotechnology industries. The company specializes in facilitating the discovery and production of small molecule pharmaceuticals and innovative cell and gene therapies.

Products and Services
  • Comprehensive contract research, development, and manufacturing services
  • Biology services supporting drug discovery and clinical progression
  • Streamlined testing services for drugs and medical devices
Growth Outlook
  • Revenue of 12.44 billion CNY in Q1 2026, indicating strong demand
  • Net income of 4.65 billion CNY in Q1 2026, showcasing profitability
  • Consistent growth in cash flow, with free cash flow of 2.4 billion CNY in Q1 2026
Financial Highlights
  • Trailing twelve months (TTM) revenue of 49.5 billion CNY, reflecting robust performance
  • Net profit margin of 41.74% TTM, indicating strong operational efficiency
  • Current ratio of 3.42 TTM, demonstrating solid liquidity position
WuXi AppTec operates through six divisions, each focusing on different aspects of drug development and manufacturing. The company's extensive operational reach spans across China, Asia, the United States, and Europe, positioning it as a key player in the global healthcare sector. Founded in 2000 and headquartered in Shanghai, WuXi AppTec has established itself as a trusted partner for pharmaceutical and biotechnology clients, offering integrated solutions that expedite the market entry of new therapies. The company's commitment to innovation and quality has driven its growth, making it an attractive option for investors interested in the healthcare industry.
AI Generated • Jul 26, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

33,834

CEO

Min Zhang Chen, PhD; Ge Li, PhD; Qing Yang

Website

www.wuxiapptec.com.cn

Headquarters

Shanghai, SH 200131, CN

WUXIF Financials

Key Financial Metrics (TTM)

Gross Margin

49.24%

Operating Margin

42.66%

Net Income Margin

41.74%

Return on Equity

27.31%

Return on Capital

19.33%

Return on Assets

18.74%

Earnings Yield

4.35%

Dividend Yield

1.01%

Payout Ratio

29.56%

Stock Overview

Market Cap

$66.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.92B

Volume

106

Avg. Volume

2.78K

Financials (TTM)

Gross Profit

CN¥23.76B

Operating Income

CN¥20.85B

EBITDA

CN¥25.31B

Operating Cash Flow

CN¥17.74B

Capital Expenditure

-CN¥5.99B

Free Cash Flow

CN¥11.75B

Cash & ST Invst.

CN¥43.38B

Total Debt

CN¥8.21B

WuXi AppTec Performance Analysis

WuXi AppTec annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 5,844,438,63764.6%
20232023-12-31CNY 5,459,116,990-6.6%
20242024-12-31CNY 4,969,800,146-9.0%
20252025-12-31CNY 6,040,361,37221.5%
WuXi AppTec sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3015.4%
Q32025-09-308.0%
Q42025-12-314.7%
Q12026-03-31-1.3%
WuXi AppTec annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY 0.4255.7%
20232023-12-31CNY 0.5122.2%
20242024-12-31CNY 0.45-12.4%
20252025-12-31CNY 0.92104.7%
WuXi AppTec sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3032.8%
Q32025-09-30-28.8%
Q42025-12-31101.7%
Q12026-03-31-35.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CN¥12.44B

+28.8%

Gross Profit

CN¥6.27B

+53.6%

Gross Margin

50.40%

N/A

Market Cap

$66.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.96M

N/A

Employees

33,834

N/A

Net Income

CN¥4.65B

+26.7%

EBITDA

CN¥5.64B

+29.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CN¥43.38B

+68.5%

Total Debt

CN¥8.21B

+32.9%

Accounts Receivable

CN¥8.58B

-2.3%

Inventory

CN¥9.97B

+53.5%

Long Term Debt

CN¥2.24B

+61.0%

Short Term Debt

CN¥5.98B

+24.7%

Return on Assets

18.74%

N/A

Return on Invested Capital

23.28%

N/A

Free Cash Flow

CN¥2.40B

-2.4%

Operating Cash Flow

CN¥3.60B

+12.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IPSEYIpsen S.A.
$44.81-4.88%
UCBJYUCB S.A.
$139.01+0.71%
HOCPFHOYA Corporation
$154.17+0.00%
LZAGYLonza Group AG
$67.09+1.25%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
FFord Motor Company
$14.37+0.02%
AALAmerican Airlines Group
$14.48+0.07%

Questions About WUXIF

What is the current price of WuXi AppTec?

WuXi AppTec is trading at $22.70 per share.

What is the 52-week range for WuXi AppTec?

Over the past 52 weeks, WuXi AppTec has traded between $7.32 and $22.70.

How much debt does WuXi AppTec have?

As of the most recent reporting period, WuXi AppTec reported total debt of CN¥1.21B.

How much cash does WuXi AppTec have on hand?

WuXi AppTec reported CN¥3.97B in cash and cash equivalents in its most recent financial results.

What is WuXi AppTec’s dividend yield?

WuXi AppTec currently has a dividend yield of 1.01%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services